Depression Clinical Trials in Dallas, TX

Depression Clinical Trials in Dallas, TX

View the best 10 depression medical studies in Dallas, Texas. Access promising new therapies by applying to a Dallas-based Depression clinical trial.

Trials in Dallas, Texas

Here are the top 10 medical studies for depression in Dallas, Texas

Image of Anderson Clinical Research in Redlands, United States.

SEP-363856 & ADT (Antidepressant Therapy)

Verified
Recruiting0 awardsPhase 2 & 3
A Phase 2/3 Trial is designed to evaluate SEP-363856 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder
Image of Advanced Research Center /ID# 227073 in Anaheim, United States.

Placebo +1 More

Pharmacotherapy

Recruiting1 awardPhase 3
This trial is testing the safety and effectiveness of Cariprazine for treating depressive episodes in children and teenagers with bipolar I disorder. The goal is to find out if Cariprazine can help young people with this condition. Cariprazine is an atypical antipsychotic recently approved for the treatment of depressive episodes in adults with bipolar I disorder.
Image of Clinical Site in Pico Rivera, United States.

Lumateperone 42 mg

Recruiting1 awardPhase 3
This trial is testing lumateperone, a medication that may help people with depression who haven't improved with other treatments. The study includes patients diagnosed with Major Depressive Disorder who haven't responded well to their current antidepressants. Lumateperone works by balancing brain chemicals that affect mood, potentially improving depressive symptoms.
Image of Neurocrine Clinical Site in Lemon Grove, United States.

NBI-1070770

Behavioural Intervention

Recruiting0 awardsPhase 2
"This trial will test whether a new medication, NBI-1070770, is better than a placebo at reducing symptoms of depression in people with major depressive disorder."
Image of UT Southwestern Medical Center in Dallas, United States.

Ketamine Hydrochloride

NMDA Receptor Antagonist

Recruiting0 awardsPhase 2
This trial is looking at how different drugs affect people with depression who also have problems with irritability.
Image of Synexus – Atlanta in Sandy Springs, United States.

NMRA-335140

Behavioural Intervention

Verified
Recruiting1 awardPhase 3
This trial is testing a new medication called NMRA-335140 to see if it can help people with severe depression. The study involves participants with Major Depressive Disorder and aims to find out if the medication can improve their mood by altering brain chemicals.
Image of Ann & Robert H. Lurie Children's Hospital of Chicago in Chicago, United States.

Competent Adulthood Transition with Cognitive-Behavioral, Humanistic and Interpersonal Training

Behavioral Intervention

Recruiting1 award2 criteria
This trial aims to prevent depression in at-risk teenagers using the CATCH-IT program. The program teaches skills to manage thoughts, behaviors, and relationships through various therapies. The goal is to make the program effective, easy to use, and widely available. CATCH-IT is an online depression prevention intervention that has been tested in various studies for its effectiveness in preventing depressive episodes among adolescents.
Image of Recovery Resource Council East Campus in Dallas, United States.

Treatment

Recruiting1 award
This trial is being conducted by the Recovery Resource Council (RRC), a non-profit organization that provides mental and behavioral healthcare services in North Texas. One of their programs offers free counseling services to U.S
Image of Clinical Site in Anaheim, United States.

Lumateperone

Behavioural Intervention

Recruiting1 awardPhase 3
"This trial is studying the effectiveness of a new treatment for children with bipolar disorder who are also experiencing major depressive episodes. The study is being conducted at multiple locations and will involve random assignment of participants to receive
Image of VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX in Dallas, United States.

Behavioral Intervention Group (MOTIVATE)

Behavioral Intervention

Recruiting1 award4 criteria
This trial will test a new pain management program for older Veterans with both chronic pain and depression.

Phase 3 Trials

Trials With No Placebo

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.